<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To assess the prevalence of urinary albumin excretion abnormalities and their associations with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> or its classical risk factors in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, 1348 clinic-proceeding patients have been studied retrospectively </plain></SENT>
<SENT sid="1" pm="."><plain>The overnight urinary albumin excretion rate, blood pressure, smoking, ophthalmic and cardiovascular status, current therapies, estimates of glycemic control, plasma <z:chebi fb="23" ids="18059">lipids</z:chebi>, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> and <z:chebi fb="3" ids="27226">uric acid</z:chebi> have been ascertained </plain></SENT>
<SENT sid="2" pm="."><plain>767 (56.8%) patients were found normoalbuminuric, 461 (34.1%) microalbuminuric and 120 (8.9%) macroalbuminuric </plain></SENT>
<SENT sid="3" pm="."><plain>In bivariate analyses, the urinary albumin excretion rate had statistically significant (P &lt; 0.05) relationships with age, duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, male sex, waist-to-hip ratio, systolic and diastolic pressure, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, cerebrovascular disease, <z:hpo ids='HP_0004950'>peripheral vascular disease</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> therapy, laser-treated <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, kind of treatment, smoking habit, fasting glycaemia, HbA1c, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, <z:chebi fb="3" ids="27226">uric acid</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>)-cholesterol and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B </plain></SENT>
<SENT sid="4" pm="."><plain>Borderline statistically significant (P &lt; 0.1) relationships were found with hypolipidaemic therapy, insulin dose, non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A1 and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) </plain></SENT>
<SENT sid="5" pm="."><plain>In a multivariate stepwise logistic regression model, HbA1c, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, male sex, age, diastolic blood pressure, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> and body-mass index were sequentially selected as variables independently associated with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, HbA1c, male sex and <z:hpo ids='HP_0000822'>hypertension</z:hpo> were sequentially selected as independently associated with macroalbuminuria </plain></SENT>
<SENT sid="7" pm="."><plain>Micro and macroalbuminuria are frequent abnormalities associated with poorly controlled and complicated disease, with overt <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and its classical risk factors as well as with the male sex </plain></SENT>
</text></document>